Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial
Resource Type
Article
Authors
Gershenson, David M ; Miller, Austin ; Brady, William E ; Paul, James ; Carty, Karen ; Rodgers, William ; Millan, David ; Coleman, Robert L ; Moore, Kathleen N ; Banerjee, Susana ; Connolly, Kate ; Secord, Angeles Alvarez ; O'Malley, David M ; Dorigo, Oliver ; Gaillard, Stephanie ; Gabra, Hani ; Slomovitz, Brian ; Hanjani, Parviz ; Farley, John ; Churchman, Michael ; Ewing, Ailith ; Hollis, Robert L ; Herrington, C Simon ; Huang, Helen Q ; Wenzel, Lari ; Gourley, Charlie
Source
In The Lancet 5-11 February 2022 399(10324):541-553
Subject
Primary Research Articles
Language
ISSN
0140-6736